You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SO-C101

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (SO-C101, pembrolizumab)

Recruiting
  • Thyroid
  • +18 more
  • New Haven, Connecticut
  • +6 more
Apr 8, 2022

Hepatocellular Carcinoma Trial in Shanghai (Ori-C101)

Recruiting
  • Hepatocellular Carcinoma
  • Ori-C101
  • Shanghai, China
    Zhongshan Hospital Fudan University
Dec 21, 2022

DFNB9 Trial (OTOV101N+OTOV101C Injections)

Not yet recruiting
  • DFNB9
  • OTOV101N+OTOV101C Injections
  • (no location specified)
Jun 2, 2023

COVID-19 Trial (Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C), Recombinant COVID-19

Not yet recruiting
  • COVID-19
  • Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C)
  • Recombinant COVID-19 vaccine(Sf9 Cell) (WSK-V101)
  • (no location specified)
Jun 19, 2023

Peanut Allergy Trial in Worldwide (AR101 powder provided in capsules & sachets, Placebo powder provided in capsules & sachets)

Completed
Has Results
  • Peanut Allergy
  • AR101 powder provided in capsules & sachets
  • Placebo powder provided in capsules & sachets
  • Bordeaux Cedex, France
  • +17 more
Jul 13, 2021

Bradycardia Trial (CARDIX-101A, CARDIX-101B, CARDIX-101C)

Not yet recruiting
  • Bradycardia
  • CARDIX-101A, CARDIX-101B, CARDIX-101C
  • (no location specified)
Jul 18, 2022

Muscular Atrophy, Spinal Trial in Argentina, Brazil (OAV101)

Active, not recruiting
  • Muscular Atrophy, Spinal
  • OAV101
  • Caba, Buenos Aires, Argentina
  • +4 more
Oct 2, 2022

Low-grade Glioma Trial (DAY101, Chemotherapeutic Agent)

Not yet recruiting
  • Low-grade Glioma
  • (no location specified)
Oct 3, 2022

Healthy Subjects, Submental Fat Trial in Seongnam (Polyene Phosphatidylcholine)

Not yet recruiting
  • Healthy Subjects
  • Submental Fat
  • Polyene Phosphatidylcholine
  • Seongnam, Gyeonggi, Korea, Republic of
    Seoul National University Bundang Hospital
Jul 25, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Decitabine and

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Decitabine and Cedazuridine
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 25, 2022

Pertussis/Whooping Cough Trial in Southampton (Bordetella pertussis B1917, Azithromycin Pill)

Recruiting
  • Pertussis/Whooping Cough
  • Bordetella pertussis B1917
  • Azithromycin Pill
  • Southampton, Hampshire, United Kingdom
    NIHR Clinical Research Facility
Apr 26, 2023

Hepatocellular Carcinoma Trial in Pavia (TAC-101, Placebo)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • Pavia, Italy
    I.R.C.C.S. San Matteo University Hospital, Golgi
Jan 3, 2022

Peanut Allergy Trial in Worldwide (AR101)

Enrolling by invitation
  • Peanut Allergy
  • AR101
  • Birmingham, Alabama
  • +91 more
Feb 24, 2022

Moderate or Severe Submental Fullness Trial in Seoul (Polyene Phosphatidylcholine, Placebo)

Recruiting
  • Moderate or Severe Submental Fullness
  • Polyene Phosphatidylcholine
  • Placebo
  • Seoul, Korea, Republic of
    Chung Ang University Hospital
Mar 15, 2022

Cancer, Covid-19 Trial in Canada (IMM-101, Observation)

Active, not recruiting
  • Cancer
  • Covid-19
  • IMM-101
  • Observation
  • Hamilton, Ontario, Canada
  • +7 more
Jun 23, 2022

Amyotrophic Lateral Sclerosis, Frontotemporal Dementia Trial in Worldwide (TPN-101, 400 mg/day, Placebo)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Frontotemporal Dementia
  • TPN-101, 400 mg/day
  • Placebo
  • Orange, California
  • +4 more
Mar 9, 2022

Recurrent DLBCL, Recurrent Follicular Lymphoma, Refractory DLBCL Trial in Seattle (Laboratory Biomarker Analysis, Pembrolizumab,

Active, not recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 20, 2022

Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection, C. Diff Trial in Canada, United States (CP101)

Completed
Has Results
  • Clostridium Difficile Infection
  • +10 more
  • CP101
  • Scottsdale, Arizona
  • +56 more
Aug 10, 2022

Cervical Cancer Trial in Worldwide (Tiragolumab, Atezolizumab)

Active, not recruiting
  • Cervical Cancer
  • Phoenix, Arizona
  • +65 more
Jan 19, 2023

Relapsed/Refractory AML, AML, Adult, MDS Trial in United States (NKX101 - CAR NK cell therapy)

Recruiting
  • Relapsed/Refractory AML
  • +3 more
  • NKX101 - CAR NK cell therapy
  • Denver, Colorado
  • +6 more
Apr 8, 2022

Sedative, Hypnotic, or Anxiolytic Withdrawal, Airway Control Trial in Beijing (Respiratory Humidification Treatment Device,

Recruiting
  • Sedative, Hypnotic, or Anxiolytic Withdrawal
  • Airway Control
  • Respiratory Humidification Treatment Device, AIRVO 2 PT101AZ, Fisher & Paykel Healthcare, Inc.
  • +11 more
  • Beijing, Beijing, China
    Peking University Hospital of Stomatology
Apr 4, 2022

Leber Congenital Amaurosis 10, Inherited Retinal Dystrophies, Eye Diseases, Hereditary Trial in United States (EDIT-101)

Active, not recruiting
  • Leber Congenital Amaurosis 10
  • +6 more
  • Miami, Florida
  • +4 more
Dec 2, 2022

Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,

Active, not recruiting
  • Prolymphocytic Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 7, 2022

Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)

Recruiting
  • Mild Cognitive Impairment
  • Alzheimer Disease
  • Canakinumab
  • Placebo
  • Charlestown, Massachusetts
  • +11 more
Nov 11, 2022

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Houston (Rituximab, Zanubrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022